ACRO BIOMEDICAL CO., LTD. (ACBM) stock: key figures, P/E, revenue and dividend

Communication Services · United States · ISIN US0048921052

Price
0.03 USD
Market cap
1.56 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

ACRO BIOMEDICAL CO., LTD. financials

Fiscal year2025
Revenue0.00 USD
Operating income-154,024.00 USD
EBIT-101,146.00 USD
Net income-101,146.00 USD
Diluted EPS – continuing operations0.00 USD

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About ACRO BIOMEDICAL CO., LTD.

Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products in Indiana and internationally. It is involved in the development and sale of cordyceps related products, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.